Our Strategy for Innovation
Investment Principles
At B-Light, investment is not just about returns—it is about advancing innovation,
driving healthy growth, and building a sustainable ecosystem.
Every decision is grounded in our mission and four core principles.
B-Light Investment prioritizes not only financial returns but also the synergetic growth of our portfolio companies and their ultimate contribution to the healthier development of society as a whole. As a steadfast partner to innovative enterprises, our goal is to pursue mutual and long-term growth.
We go beyond investment itself by actively engaging and supporting the practical success of our portfolio companies. Leveraging the Open Innovation Team as our ‘execution engine,’ we evaluate commercialization potential from the deal-sourcing stage and, post-investment, drive comprehensive business execution—including sales, marketing, PMI (post-merger integration), and global expansion—to accelerate corporate growth.
To enhance both the accuracy and depth of our investment decisions, we actively incorporate the profound insights of external experts and in-depth evaluations of technology and commercialization potential. In parallel, we combine these with the strategic judgment and financial analysis of our internal executive committee. Through this hybrid investment review process, we pursue optimal decision-making that maximizes both expertise and efficiency.
By discovering and advancing innovative bio companies, we strive to contribute beyond the growth of individual enterprises—toward building a thriving and healthy bio-healthcare ecosystem. In doing so, we work to realize our ultimate vision of enhancing human quality of life and fostering a virtuous cycle for a healthier world.
OUR ACTIVE ROLE
Driving growth through hands-on execution after investment.
As the core driver of our group’s new healthcare initiatives, the Open Innovation Team
acts as a powerful execution partner—turning potential into measurable success.
We accelerate growth by fulfilling four key roles
Step 01
Following an investment, our Open Innovation Team partners together with companies to refine and implement commercialization strategies. From market entry to sales and marketing plans, we go beyond traditional advisory—working on the ground alongside management to deliver tangible results.
Step 02
For companies seeking to enter major markets such as the United States and China, we directly connect them with the Open Innovation Team’s global network and expertise in distribution and sales, accumulated through the group’s new businesses.
We provide execution plans that address local challenges, accelerate international growth, and create synergies across our broader portfolio.
Step 03
We establish and monitor growth-aligning key performance indicators (KPIs) for portfolio companies.
Acting as a Project Management Office (PMO), we provide structured support across operations—from achieving technology milestones to hitting revenue targets—ensuring consistent execution and performance.
Step 04
We actively identify and mitigate risks in the highly volatile bio-healthcare market.
By monitoring industry and market trends, supporting scenario planning, and preparing emergency response strategies, we help companies remain resilient and sustain long-term growth.
